Craig A. Tooman
Chief Financial Officer, Enzon Pharmaceuticals.
Companies
- Silence TherapeuticsBoard member Jan 2, 2025 to Jan 6, 20251
- Silence TherapeuticsChief executive officer Jan 2, 2025 to Jan 6, 20251
- Silence TherapeuticsPresident Jan 2, 2025 to Jan 6, 20251
- Enzon PharmaceuticalsChief financial officer Mar 7, 2006 to Jun 22, 20102
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Silence Therapeutics SLN33,486 shares3$655.5K at $19.57Jan 2, 2025
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSilence Therapeutics, Board member
- 2
- 3